Navigation Links
Sundia Appoints Charles D. Maher as Senior Vice President of Sales and Marketing

SHANGHAI, Oct. 15 /PRNewswire-Asia/ -- Sundia MediTech, a leading pharmaceutical R&D outsourcing service company in China, announced today that Mr. Charles D. Maher has been appointed Senior Vice President of Sales and Marketing of Sundia.

Prior to joining Sundia, Mr. Maher was Executive Vice President of Global Sales and Marketing of Azopharma Product Development Group, a CRO company in Florida, USA. Azopharma's CRO service scope covers chemical synthesis, analytical, API, preclinical and clinical operations. Mr. Maher was responsible for development and execution of worldwide strategies, and the recruiting and training of business development managers and directors. Mr. Maher previously also worked for Proceryon Biosciences, a CRO company in New York, as Senior Vice President of Business Development for ten years, and for Bio-Rad Laboratories in USA as Director of Sales for eight years.

Mr. Maher has extensive experience in leading many aspects of CRO industry operations, and has accumulated a consistent track record of improving bottom line by growing revenue, reducing costs and maximizing employee productivity through his career.

In his new role in Sundia, Mr. Maher will be responsible for Sundia's business development in global market. Mr. Maher will report directly to Dr. Xiaochuan Wang, Chairman and CEO of Sundia.

"Mr. Maher's past experience is a perfect match to Sundia's business needs. I am very pleased to welcome him to join our team at this very important point of Sundia's development," commented Dr. Xiaochuan Wang. "With the rapid growth of Sundia, we need more experienced and high quality leaders in the company. I have full confidence that our business development team will deliver a outstanding result under the leadership of Mr. Maher."

Mr. Maher had his college education in Miami University with a double major in marketing management and chemistry, and obtained his MBA degree from Ohio State University in USA.

About Sundia MediTech

Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) based in Shanghai, China. It was founded in Shanghai in 2004 by a group of U.S. pharmaceutical industry veterans to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide.

SOURCE Sundia MediTech Company

SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
2. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
3. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
4. Sundias Animal Facility Passed Client and Government Inspection
5. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
6. Sundia MediTech Appoints Dr. Tong Xu as VP of Process Chemistry
7. Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology
8. Sundia in Top 100 Fast-growth Outsourcing Companies in China
9. Sundia Shortens CRO Shipment Delivery Time with Express Customs Clearance in Shanghai
10. Sundia Welcomes Professional U.S. Delegation
11. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
Post Your Comments:
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... Supplyframe, the Industry Network for electronics hardware design and ... in Pasadena, Calif., the Design Lab’s mission is to bring together inventors and ... brought to market. , The Design Lab is Supplyframe’s physical representation of one ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
Breaking Biology Technology:
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
Breaking Biology News(10 mins):